Advisor Group Holdings, Inc. Heron Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

  • $52.6 Billion
  • Q2 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 3,968 shares of HRTX stock, worth $4,682. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,968
Previous 968 309.92%
Holding current value
$4,682
Previous $2,000 300.0%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Sep 04, 2025
BUY
$1.72 - $2.42 $5,160 - $7,260
3,000 Added 309.92%
3,968 $8,000
Q1 2025

May 12, 2025
SELL
$1.47 - $2.55 $648 - $1,124
-441 Reduced 31.3%
968 $2,000
Q3 2024

Nov 13, 2024
SELL
$1.73 - $3.67 $458 - $972
-265 Reduced 15.83%
1,409 $2,000
Q2 2024

Aug 13, 2024
SELL
$2.32 - $3.86 $35,978 - $59,860
-15,508 Reduced 90.26%
1,674 $5,000
Q1 2024

May 10, 2024
BUY
$1.71 - $3.06 $1,723 - $3,084
1,008 Added 6.23%
17,182 $47,000
Q4 2023

Feb 12, 2024
SELL
$0.54 - $1.82 $1,611 - $5,430
-2,984 Reduced 15.58%
16,174 $27,000
Q3 2023

Nov 13, 2023
SELL
$0.97 - $1.8 $251 - $466
-259 Reduced 1.33%
19,158 $19,000
Q2 2023

Aug 10, 2023
SELL
$1.11 - $2.88 $1,743 - $4,524
-1,571 Reduced 7.49%
19,417 $22,000
Q1 2023

May 12, 2023
SELL
$1.51 - $3.25 $906 - $1,950
-600 Reduced 2.78%
20,988 $31,000
Q4 2022

Feb 10, 2023
BUY
$2.25 - $4.67 $3,017 - $6,262
1,341 Added 6.62%
21,588 $53,000
Q3 2022

Nov 14, 2022
SELL
$2.66 - $5.37 $2,008 - $4,054
-755 Reduced 3.59%
20,247 $85,000
Q2 2022

Aug 10, 2022
BUY
$2.3 - $6.29 $1,948 - $5,327
847 Added 4.2%
21,002 $58,000
Q1 2022

May 04, 2022
SELL
$4.63 - $9.94 $103,415 - $222,019
-22,336 Reduced 52.57%
20,155 $115,000
Q3 2021

Nov 05, 2021
BUY
$10.13 - $15.0 $5,551 - $8,220
548 Added 1.31%
42,491 $456,000
Q2 2021

Aug 02, 2021
BUY
$13.27 - $18.48 $136,787 - $190,491
10,308 Added 32.58%
41,943 $652,000
Q1 2021

May 13, 2021
BUY
$14.49 - $20.72 $304,855 - $435,928
21,039 Added 198.56%
31,635 $513,000
Q4 2020

Feb 10, 2021
BUY
$14.61 - $22.14 $30,695 - $46,516
2,101 Added 24.73%
10,596 $223,000
Q3 2020

Nov 12, 2020
SELL
$13.67 - $17.77 $3,048 - $3,962
-223 Reduced 2.56%
8,495 $126,000
Q2 2020

Aug 14, 2020
BUY
$10.89 - $21.47 $73,507 - $144,922
6,750 Added 342.99%
8,718 $128,000
Q1 2020

May 18, 2020
BUY
$10.23 - $24.56 $20,132 - $48,334
1,968 New
1,968 $23,000

Others Institutions Holding HRTX

# of Institutions
184
Shares Held
128M
Call Options Held
1.56M
Put Options Held
27.1K
View Full List

About HERON THERAPEUTICS, INC.

HRTX Quotes by TradingView
  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $140M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email